A Fatal Case of Agranulocytosis Due to Thenalidine Tartrate Complicated by Acute Renal Failure and Mycelial Abscesses of Brain

Abstract

Get full access to this article

View all access options for this article.

References

Adams

D. A.

Perry

(1958). Agranulocytosis associated with thenalidine (Sandosten) tartrate therapy. J. Amer. med. Ass., 167, 1207.

Blanton

W. B.

Owens

M. E. B.

(1947). Granulocytopenia due probably to Pyribenzamine. J. Amer. med. Ass., 134, 454.

Cahan

A. M.

Meilman

Jacobson

B. M.

(1949). Agranulocytosis following Pyribenzamine. New Engl. J. Med., 241, 865.

Crumbley

J. J.

(1950). Anemia following use of antihistaminic drugs. J. Amer. med. Ass., 143, 726.

Drake

T. G.

(1950). Agranulocytosis during therapy with the antihistaminic agent methaphenilene (Diatrin). J. Amer. med. Ass., 142, 477.

Hilker

A. W.

(1950). Agranulocytosis from tripelennamine (Pyribenzamine) hydrochloride. J. Amer. med. Ass., 143, 741.

Martland

H. S.

Guck

J. K.

(1950). Agranulocytosis after antihistaminic therapy. Report of a case following the prolonged use of tripelennamine (Pyribenzamine) hydrochloride. J. Amer. med. Ass., 143, 742.

Parrish

A. E.

Rubenstein

N. H.

Howe

J. S.

(1955). Acute renal insufficiency associated with respiratory infections. Amer. J. Med., 18, 237.

Schultz

(1922). Ueber eigenartige Halserkrankungen. Dtsch. med. Wschr., 48, 1495.

10.

Thal

(1955). Selective renal vasospasm and ischemic renal necrosis produced experimentally with staphylococcal toxin. Amer. J. Path., 31, 233.

11.

Wyngaarden

J. B.

Seevers

M. H.

(1951). The toxic effects of antihistaminic drugs. J. Amer. med. Ass., 145, 277.

12.

Zolov

(1958). Agranulocytosis resulting from Sandosten. J. Maine med. Ass., 49, 335.